Indoor Fungal Exposure and Allergic Respiratory Disease

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Hill DJ, Munro DA, West PJ, Knox RB, Weston RH. Asthma in Melbourne children. Med J Aust. 1978;1:614–5.PubMedGoogle Scholar
2. 2.
   Pepys J. Allergenic hypersensitivity to fungi. Postgraduate J Med. 1959;35:436–40.CrossRefGoogle Scholar
3. 3.
   Crameri R, Garbani M, Rhyner C, Huitema C. Fungi: the neglected allergenic sources. Allergy. 2014;69:176–85.CrossRefPubMedGoogle Scholar
4. 4.
   Arundel AV, Sterling EM, Biggin JH, Sterling TD. Indirect health effects of relative humidity in indoor environments. Environ Health Perspect. 1986;65:351–61.PubMedCentralPubMedGoogle Scholar
5. 5.
   Asher M, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–43.CrossRefPubMedGoogle Scholar
6. 6.
   Terr AI. Are indoor molds causing a new disease? J Allergy Clin Immunol. 2004;113:221–6.CrossRefPubMedGoogle Scholar
7. 7.
   Jacobs J, Borràs-Santos A, Krop E, Täubel M, Leppänen H, Haverinen-Shaughnessy U, et al. Dampness, bacterial and fungal components in dust in primary schools and respiratory health in schoolchildren across Europe. Occup Environ Med. 2014;71:704–12.CrossRefPubMedGoogle Scholar
8. 8.
   Wilkins K, Nielsen K, Din S. Patterns of volatile metabolites and nonvolatile trichothecenes produced by isolates of stachybotrys, Fusarium, Trichoderma, trichothecium and memnoniella. Environ Sci Pollut Res. 2003;10:162–6.CrossRefGoogle Scholar
9. 9.
   O'Driscoll BR, Powell G, Chew F, Niven RM, Miles JF, Vyas A, et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy. 2009;39:1677–83.CrossRefPubMedGoogle Scholar
10. 10.
    Smith M, Jäger S, Berger U, Šikoparija B, Hallsdottir M, Sauliene I, et al. Geographic and temporal variations in pollen exposure across Europe. Allergy. 2014;69:913–23.CrossRefPubMedGoogle Scholar
11. 11.
    Burge HA. An update on pollen and fungal spore aerobiology. J Allergy Clin Immunol. 2002;110:544–52.CrossRefPubMedGoogle Scholar
12. 12.
    Vesper S, McKinstry C, Haugland R, Wymer L, Bradham K, Ashley P, et al. Development of an environmental relative moldiness index for US homes. J Occup Environ Med. 2007;49:829–33.CrossRefPubMedGoogle Scholar
13. 13.
    Vesper SJ et al. Comparison of populations of mould species in homes in the UK and USA using mould-specific quantitative PCR. Appl Microbiol. 2005;41:367–73.CrossRefGoogle Scholar
14. 14.
    Vesper S, Wakefield J, Ashley P, Cox D, Dewalt G, Friedman W. Geographic distribution of environmental relative moldiness index molds in USA homes. J Environ Public Health. 2011;2011:11.CrossRefGoogle Scholar
15. 15.
    Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107–19.CrossRefPubMedGoogle Scholar
16. 16.
    Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355–60.CrossRefPubMedGoogle Scholar
17. 17.
    Jacobsen EA, Lee NA, Lee JJ. Re-defining the unique roles for eosinophils in allergic respiratory inflammation. Clin Exp Allergy. 2014;44:1119–36.PubMedCentralCrossRefPubMedGoogle Scholar
18. 18.
    Casas L, Tischer C, Wouters IM, Torrent M, Gehring U, Garcia-Esteban R, et al. Early life microbial exposure and fractional exhaled nitric oxide in school-age children: a prospective birth cohort study. Environ Heal. 2013;12:103.CrossRefGoogle Scholar
19. 19.
    Sachs-Olsen C, Lødrup Carlsen KC, Mowinckel P, Håland G, Devulapalli CS, Munthe-Kaas MC, et al. Diagnostic value of exhaled nitric oxide in childhood asthma and allergy. Pediatr Allergy Immunol. 2010;21:e213–21.CrossRefPubMedGoogle Scholar
20. 20.
    Blackwell M. The fungi: 1, 2, 3 … 5.1 million species? Am J Bot. 2011;98:426–38.CrossRefPubMedGoogle Scholar
21. 21.
    Thornton CR, Wills OE. Immunodetection of fungal and oomycete pathogens: established and emerging threats to human health, animal welfare and global food security. Crit Rev Microbiol. 2015;41:27–51.CrossRefPubMedGoogle Scholar
22. 22.
    Davies GE, Thornton CR. Differentiation of the emerging human pathogens trichosporon asahii and trichosporon asteroides from other pathogenic yeasts and moulds by using species-specific monoclonal antibodies. Plos One. 2014;9(1):e84789.PubMedCentralCrossRefPubMedGoogle Scholar
23. 23.
    Miyagawa T, Hamagami S, Tanigawa N. Cryptococcus albidus-induced summer-type hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2000;161:961–6.CrossRefPubMedGoogle Scholar
24. 24.
    Thornton CR. Breaking the mould—novel diagnostic and therapeutic strategies for invasive pulmonary aspergillosis in the immune deficient patient. Expert Rev Clin Immunol. 2014;10:771–80.CrossRefPubMedGoogle Scholar
25. 25.
    Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13.CrossRefPubMedGoogle Scholar
26. 26.
    Prattes J, Flick H, Prueler F, Koidi C, Raggam RB, Palfner M, et al. Novel tests for diagnosis of invasive Aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014;190:922–9.CrossRefPubMedGoogle Scholar
27. 27.
    Huerta A, Soler N, Esperatti M, Guerrero M, Menendez R, Gimeno A, et al. Importance of aspergillus spp. Isolation in acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respir Res. 2014;15:17.PubMedCentralCrossRefPubMedGoogle Scholar
28. 28.
    Thornton CR. Tracking the emerging human pathogen pseudallescheria boydii by using highly specific monoclonal antibodies. Clin Vaccine Immunol. 2009;16:756–64.PubMedCentralCrossRefPubMedGoogle Scholar
29. 29.
    Thornton CR, Ryder LS, Le Cocq K, Soanes DM. Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase. Environ Microbiol. 2015;17:1023–38.CrossRefPubMedGoogle Scholar
30. 30.
    Barton RC, Borman AM, Johnson EM, Houbraken J, Hobson RP, Denton M, et al. Isolation of the fungus geosmithia argillacea in sputum of people with cystic fibrosis. J Clin Microbiol. 2010;48:2615–7.PubMedCentralCrossRefPubMedGoogle Scholar
31. 31.
    Nagano Y, Millar BC, Johnson E, Goldsmith CE, Elborn JS, Rendall J, et al. Fungal infections in patients with cystic fibrosis. Rev Med Microbiol. 2007;18:11–6.CrossRefGoogle Scholar
32. 32.
    Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J. 2006;27:615–26.CrossRefPubMedGoogle Scholar
33. 33.
    Denning DW, Pleuvry A, Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Med Mycol. 2013;51:361–70.CrossRefPubMedGoogle Scholar
34. 34.
    Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011; 2011:843763.Google Scholar
35. 35.
    Kurup VP. Aspergillus antigens: which are important? Med Mycol. 2005;43:S189–96.CrossRefPubMedGoogle Scholar
36. 36.
    De Hoog GS, Queiroz-Telles F, Haase G, Fernandez-Zeppenfeldt G, Angelis DA, Van den Ende AHGG, et al. Black fungi: clinical and pathogenic approaches. Med Mycol. 2000;38:243–50.CrossRefPubMedGoogle Scholar
37. 37.
    Chou H, Tam MF, Lee LH, Chiang CH, Tai HY, Panzani RC, et al. Vacuolar serine protease is a major allergen of cladosporium cladosporioides. Int Arch Allergy Immunol. 2008;146:277–86.CrossRefPubMedGoogle Scholar
38. 38.
    Vojdani A. Antibodies against Stachybotrys chartarum extract and its antigenic components, stachyhemolysin and stachyrase-A: a new clinical biomarker. Med Sci Monit. 2005;11:BR139–45.PubMedGoogle Scholar
39. 39.
    Wartenberg D, Lapp K, Jacobsen ID, Dahse H-M, Kniemeyer O, Heinekamp T, et al. Secretome analysis of aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol. 2011;301:602–11.CrossRefPubMedGoogle Scholar
40. 40.
    Pringle A. Asthma and the diversity of fungal spores in air. PLoS Pathog. 2013;9:e1003371.PubMedCentralCrossRefPubMedGoogle Scholar
41. 41.••
    Sharpe RA, Bearman N, Thornton CR, Husk K, Osborne NJ. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol. 2014;135:110–22. First systematic review and meta-analysis on the diversity and concentrations of indoor fungi, which highlights a number of limitations with the inconsistency and difficulty in assessing the role of indoor fungal species on health.Google Scholar
42. 42.•
    Quansah R, Jaakkola MS, Hugg TT, Heikkinen SAM, Jaakkola JJK. Residential dampness and molds and the risk of developing asthma: a 7-12 july 2014 systematic review and meta-analysis. PLoS ONE. 2012;7:e47526. Builds on the reviews of Fisk and Mendell and is the first to implicate exposure to fungi and risk of developing allergic diseases.Google Scholar
43. 43.
    Fisk WJ, Lei-Gomez Q, Mendell MJ. Meta-analyses of the associations of respiratory health effects with dampness and mold in homes. Indoor Air. 2007;17:284–96.CrossRefPubMedGoogle Scholar
44. 44.
    Nevalainen A, Täubel M, Hyvärinen A. Indoor fungi: companions and contaminants. Indoor Air. 2015;25:125–56.CrossRefPubMedGoogle Scholar
45. 45.
    Sharpe R, Thornton CR, Osborne NJ. Modifiable factors governing indoor fungal diversity and risk of asthma. Clin Exp Allergy. 2014;44:631–41.CrossRefPubMedGoogle Scholar
46. 46.
    Barberán A, Dunn RR, Reich BJ, Pacifici K, Laber EB, Menninger HL, et al. The ecology of microscopic life in household dust. Proc R Soc Lond B Biol Sci 2015; 282.Google Scholar
47. 47.
    Méheust D, Le Cann P, Reboux G, Millon L, Gangneux J-P. Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces. Crit Rev Microbiol. 2013;0:1–13.Google Scholar
48. 48.
    Frankel M, Bekö G, Timm M, Gustavsen S, Hansen EW, Madsen AM. Seasonal variations of indoor microbial exposures and their relation to temperature, relative humidity, and Air exchange rate. Appl Environ Microbiol. 2012;78:8289–97.PubMedCentralCrossRefPubMedGoogle Scholar
49. 49.
    Johansson P, Bok G, Ekstrand-Tobin A. The effect of cyclic moisture and temperature on mould growth on wood compared to steady state conditions. Build Environ. 2013;65:178–84.CrossRefGoogle Scholar
50. 50.
    Mensah-Attipoe J, Reponen T, Salmela A, Veijalainen A-M, Pasanen P. Susceptibility of green and conventional building materials to microbial growth. Indoor Air 2014:(accepted).Google Scholar
51. 51.
    Andersen B, Frisvad JC, Søndergaard I, Rasmussen IS, Larsen LS. Associations between fungal species and water-damaged building materials. Appl Environ Microbiol. 2011;77:4180–8.PubMedCentralCrossRefPubMedGoogle Scholar
52. 52.
    Verdier T, Coutand M, Bertron A, Roques C. A review of indoor microbial growth across building materials and sampling and analysis methods. Build Environ. 2014;80:136–49.CrossRefGoogle Scholar
53. 53.
    Flannigan B, Samson RA, Miller JD. Microorganisms in home and indoor work environments - diversity, health impacts, investigation and control. 2nd ed. Florida: CRC Press; 2011.CrossRefGoogle Scholar
54. 54.
    Reponen T, Singh U, Schaffer C, Vesper S, Johansson E, Adhikari A, et al. Visually observed mold and moldy odor versus quantitatively measured microbial exposure in homes. Sci Total Environ. 2010;408:5565–74.PubMedCentralCrossRefPubMedGoogle Scholar
55. 55.
    Haverinen-Shaughnessy U. Prevalence of dampness and mold in European housing stock. J Expo Sci Environ Epidemiol. 2012;22:461–7.CrossRefPubMedGoogle Scholar
56. 56.
    Sharpe RA, Thornton CR, Nikolaou V, Osborne NJ. Fuel poverty increases risk of mould contamination, regardless of adult risk perception & ventilation in social housing properties. Environ Int. 2015;79:115–29.CrossRefPubMedGoogle Scholar
57. 57.
    Frankel M, Hansen EW, Madsen AM. Effect of relative humidity on the aerosolization and total inflammatory potential of fungal particles from dust-inoculated gypsum boards. Indoor Air. 2014;24:16–28.CrossRefPubMedGoogle Scholar
58. 58.
    Seo S, Choung JT, Chen BT, Lindsley WG, Kim KY. The level of submicron fungal fragments in homes with asthmatic children. Environ Res. 2014;131:71–6.CrossRefPubMedGoogle Scholar
59. 59.
    Sharpe RA, Thornton CR, Nikolaou V, Osborne NJ. Higher energy efficient homes are associated with increased risk of doctor diagnosed asthma in a UK sub population. Environ Int. 2015;75:234–44.CrossRefPubMedGoogle Scholar
60. 60.•
    Sharpe RA, Thornton CR, Tyrrell J, Nikolaou V, Osborne NJ. Variable risk of atopic disease due to indoor fungal exposure in NHANES 2005–2006. Clin Exp Allergy. 2015;45:1566–78. Highlights the complexity of investigating indoor fungi and interaction with the indoor microbiome, but also the role of allergic and non-allergic mechanisms.Google Scholar
61. 61.•
    Hernberg S, Sripaiboonkij P, Quansah R, Jaakkola JK, Jaakkola MS. Indoor molds and lung function in healthy adults. Respir Med. 2014;108:677–84. Demonstrates the inflammatory potential in healthy populations.Google Scholar
62. 62.
    Larsson M, Hägerhed-Engman L, Moniruzzaman S, Janson S, Sundell J, Bornehag C-G. Can we trust cross-sectional studies when studying the risk of moisture-related problems indoor for asthma in children? Int J Environ Health Res. 2011;21:237–47.CrossRefPubMedGoogle Scholar
63. 63.
    Hägerhed-Engman L, Sigsgaard T, Samuelson I, Sundell J, Janson S, Bornehag CG. Low home ventilation rate in combination with moldy odor from the building structure increase the risk for allergic symptoms in children. Indoor Air. 2009;19:184–92.CrossRefPubMedGoogle Scholar
64. 64.
    Vesper S, Barnes C, Ciaccio CE, Johanns A, Kennedy K, Murphy JS, et al. Higher environmental relative moldiness index (ERMI) values measured in homes of asthmatic children in Boston, Kansas city, and San Diego. J Asthma. 2013;50(2):155–61.CrossRefPubMedGoogle Scholar
65. 65.
    Vesper SJ, Wymer L, Kennedy S, Grimsley LF. Decreased pulmonary function measured in children exposed to high environmental relative moldiness index homes. Open Respir Med J. 2013;7:83–6.PubMedCentralCrossRefPubMedGoogle Scholar
66. 66.•
    Reponen T, Lockey J, Bernstein DI, Vesper SJ, Levin L, Hershey GKK, et al. Infant origins of childhood asthma associated with specific molds. J Allergy Clin Immunol. 2012;130:639–44. Use of the ERMI and identification of key indoor species associated with new asthma symptoms, highlighting the potential for this technique to assess indoor exposures.Google Scholar
67. 67.
    Méheust D, Le Cann P, Reponen T, Wakefield J, Vesper S, Gangneux J-P. Possible application of the environmental relative moldiness index in France: a pilot study in Brittany. Int J Hyg Environ Health. 2013;216:333–40.CrossRefPubMedGoogle Scholar
68. 68.
    McSharry C, Vesper S, Wymer L, Howieson S, Chaudhuri R, Wright GR, et al. Decreased FEV1% in asthmatic adults in Scottish homes with high environmental relative moldiness index values. ClinExp Allergy. 2015;45:902–7.CrossRefGoogle Scholar
69. 69.
    Vesper SJ, McKinstry C, Haugland RA, Iossifova Y, Lemasters G, Levin L, et al. Relative moldiness index as predictor of childhood respiratory illness. J Expo Sci Environ Epidemiol. 2006;17:88–94.PubMedCentralCrossRefPubMedGoogle Scholar
70. 70.
    Pitkäranta M, Meklin T, Hyvärinen A, Nevalainen A, Paulin L, Auvinen P, et al. Molecular profiling of fungal communities in moisture damaged buildings before and after remediation—a comparison of culture-dependent and culture-independent methods. BMC Microbiol. 2011;11:235.PubMedCentralCrossRefPubMedGoogle Scholar
71. 71.
    Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic health effects of dampness, mold, and dampness-related agents: a review of the epidemiologic evidence. Environ Health Perspect. 2011;119:748–56.PubMedCentralCrossRefPubMedGoogle Scholar
72. 72.
    Mendall M. Indoor dampness and mold as indicators of respiratory health risks, part 2: a brief update on the epidemiologic evidence. 13th International Conference on Indoor Air Quality and Climate 2014 Hong Kong, 2014.Google Scholar
73. 73.
    Antova T, Pattenden S, Brunekreef B, Heinrich J, Rudnai P, Forastiere F, et al. Exposure to indoor mould and children’s respiratory health in the PATY study. J Epidemiol Community Health. 2008;62:708–14.CrossRefPubMedGoogle Scholar
74. 74.•
    Tischer CG, Hohmann C, Thiering E, Herbarth O, Müller A, Henderson J, et al. Meta-analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative. Allergy. 2011;66:1570–9. Examined relationship between fungi and dampness and asthma and allergy across a range of populations. Google Scholar
75. 75.
    Sharpe RA, Bearman N, Thornton CR, Husk K, Osborne NJ. Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. J Allergy Clin Immunol. 2015;135:110–22.CrossRefPubMedGoogle Scholar
76. 76.
    Matheson MC, Abramson MJ, Dharmage SC, Forbes AB, Raven JM, Thien FCK, et al. Changes in indoor allergen and fungal levels predict changes in asthma activity among young adults. Clin Exp Allergy. 2005;35:907–13.CrossRefPubMedGoogle Scholar
77. 77.
    Das P, Chalabi Z, Jones B, Milner J, Shrubsole C, Davies M, et al. Multi-objective methods for determining optimal ventilation rates in dwellings. Build Environ. 2013;66:72–81.CrossRefGoogle Scholar
78. 78.
    BSI. Code of practice for control of condensation in buildings. BS 5250:2011. UK: British Standards Institute, 2011.Google Scholar
79. 79.
    Simon-Nobbe B, Denk U, Pöll V, Rid R, Breitenbach M. The spectrum of fungal allergy. Int Arch Allergy Immunol. 2008;145:58–86.CrossRefPubMedGoogle Scholar
80. 80.
    Wilkinson P, Smith KR, Beevers S, Tonne C, Oreszczyn T. Energy, energy efficiency, and the built environment. Lancet. 2007;370:1175–87.CrossRefPubMedGoogle Scholar
81. 81.
    Twaroch TE, Curin M, Valenta R, Swoboda I. Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res. 2015;7:205–20.PubMedCentralCrossRefPubMedGoogle Scholar